Retaglutide is a innovative GLP-1 receptor agonist currently under study for the management of type 2 diabetes. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://harleygqcn562587.blogaritma.com/36984764/trelaglutide-exploring-a-new-treatment-for-chronic-diseases